Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0241981 (
loss of balance
)
452
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Huntington's disease (HD) is caused by an expansion of glutamine repeats in the huntingtin protein (mHtt) that invokes early and prominent damage of the striatum, a region that controls motor behaviors. Despite its ubiquitous expression, why certain brain regions, such as the cerebellum, are relatively spared from neuronal loss by mHtt remains unclear. Previously, we implicated the striatal-enriched GTPase,
Rhes
(Ras homolog enriched in the striatum), which binds and SUMOylates mHtt and increases its solubility and cellular cytotoxicity, as the cause for striatal toxicity in HD. Here, we report that
Rhes
deletion in HD mice (N171-82Q), which express the N-terminal fragment of human Htt with 82 glutamines (
Rhes
(-/-)/N171-82Q), display markedly reduced HD-related behavioral deficits, and absence of lateral ventricle dilatation (secondary to striatal atrophy), compared to control HD mice (N171-82Q). To further validate the role of GTPase
Rhes
in HD, we tested whether ectopic
Rhes
expression would elicit a pathology in a brain region normally less affected in HD. Remarkably, ectopic expression of
Rhes
in the cerebellum of N171-82Q mice, during the asymptomatic period led to an exacerbation of motor deficits, including
loss of balance
and motor incoordination with ataxia-like features, not apparent in control-injected N171-82Q mice or
Rhes
injected wild-type mice. Pathological and biochemical analysis of
Rhes
-injected N171-82Q mice revealed a cerebellar lesion with marked loss of Purkinje neuron layer parvalbumin-immunoreactivity, induction of caspase 3 activation, and enhanced soluble forms of mHtt. Similarly reintroducing
Rhes
into the striatum of
Rhes
deleted
Rhes
(-/-)Hdh(150Q/150Q) knock-in mice, elicited a progressive HD-associated rotarod deficit. Overall, these studies establish that
Rhes
plays a pivotal role in vivo for the selective toxicity of mHtt in HD.
...
PMID:Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease. 2604 56